Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant
Article
[키워드] addition
Affect
analyzed
anti-SARS-CoV-2
anti-SARS-CoV-2 antibody
antibodies
antibody
antibody assay
Antibody assays
antigenic
antigenic structure
antigens
assays
change
changes in
characterized
controls
convalescent individual
correlation
diagnostic
immunoassay
immunoassays
immunoreactivity
impairing
individual
Infection
lack
neutralization
Neutralization assay
Neutralizing activity
Neutralizing antibodies
Neutralizing antibody titer
omicron
Primary infection
Protein
quantified
RBD
reduced
SARS-CoV-2
SARS-CoV-2-specific antibody
sensitivity
significantly
spike
statistically significant reduction
subjects
surrogate assay.
tested
the SARS-CoV-2
the Spike
variant
variants
were used
wild type
wild-type
wild-type strain
[DOI] 10.1128/spectrum.02129-22 PMC 바로가기
[DOI] 10.1128/spectrum.02129-22 PMC 바로가기